Page last updated: 2024-11-07

dextroamphetamine and Phobic Disorders

dextroamphetamine has been researched along with Phobic Disorders in 2 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneier, FR1
Abi-Dargham, A1
Martinez, D1
Slifstein, M1
Hwang, DR1
Liebowitz, MR1
Laruelle, M1
O'Brien, J1

Other Studies

2 other studies available for dextroamphetamine and Phobic Disorders

ArticleYear
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
    Depression and anxiety, 2009, Volume: 26, Issue:5

    Topics: Adult; Carbon Radioisotopes; Cocaine; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma

2009
School problems: school phobia and learning disabilities.
    The Psychiatric clinics of North America, 1982, Volume: 5, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Family; Humans;

1982